LAUSR

Peripheral ischemia in diabetic retinopathy (DR) is a sight threatening condition especially in the presence of disc or preretinal neovessels. Based on the ETDRS studies, peripheral laser photocoagulation (PRP) has been recognized for more than 30 years as the gold standard treatment for peripheral ischemia in DR. Recently, the widespread use of repetitive anti VEGF injections in the management of diabetic macular edema revealed an additive favourable effect on the regression of diabetic retinopathy severity scale. The goals of this talk are two-fold: first, to review the published evidence for the use of PRP and anti VEGF injections independently in the management of peripheral ischemia in DR; second, to discuss the associated characteristics of DR, socio economic issues that could guide the clinician into his therapeutical decision. At the end of the talk, participants should be able to take a thorough decision to guide an evidence based treatment for peripheral ischemia in DR.